Men under 50 and over 69 and those with a limited life expectancy should not be screened for prostate cancer, according to new guidelines issued by the American College of Physicians. The group called on providers to discuss with their male patients the limited benefits and "substantial" risks associated with the prostate-specific antigen test. "By and large, the data doesn't support routine screening because the outcomes aren't better," said Dr. David Bronson, president of the ACP.

Related Summaries